Related Experiment Video
Updated: Apr 24, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
3.8K
Management of giant retinal tears using microincision vitrectomy surgery
1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Developments in Ophthalmology
|September 9, 2014
Summary
Microincision vitrectomy surgery (MIVS) offers a new approach for giant retinal tears (GRTs). This technique, using perfluorocarbon liquid and silicone oil, achieves high retinal reattachment rates.
Area of Science:
- Ophthalmology
- Retinal Surgery
Background:
- Giant retinal tears (GRTs) are rare and challenging surgical cases.
- Microincision vitrectomy surgery (MIVS) represents an advancement in treating GRTs.
Purpose of the Study:
- To describe the surgical technique of MIVS for GRTs.
- To detail the complications associated with MIVS for GRTs.
Main Methods:
- Vitrectomy performed using MIVS with wide-viewing systems and chandelier illumination.
- Injection of perfluorocarbon liquid (PFCL), followed by endophotocoagulation.
- Exchange of PFCL for a 2-week silicone oil (SO) tamponade for retinal reattachment.
Main Results:
- Postoperative complications include macular pucker, subretinal PFCL, retinal folds, cystoid macular edema, and redetachment.
- All identified complications were successfully managed with medication or further surgery.
Conclusions:
- MIVS provides a feasible and effective surgical approach for GRTs.
- Combining MIVS with intraoperative PFCL and SO tamponade leads to excellent reattachment rates.
